ALKS 2680

Alkermes begins Phase II trial of ALKS 2680 for narcolepsy type 1
Clinical Trials Arena
Thu, 04/25/24 - 11:26 am
Alkermes
clinical trials
ALKS 2680
narcolepsy
Alkermes reports data from Phase Ib narcolepsy treatment trial
Clinical Trials Arena
Wed, 04/10/24 - 06:00 pm
Alkermes
clinical trials
narcolepsy
ALKS 2680
Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680
Drugs.com
Tue, 10/10/23 - 11:47 pm
Alkermes
ALKS 2680
narcolepsy